DP
JBIO

Diadema Partners’s Jade Biosciences JBIO Stock Holding History

Diadema Partners’s Portfolio JBIO Stock Details JBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.17K Hold
1,046
– – ﹤0.01% 147
2026
Q1 		$2.93K Hold
1,046
– – ﹤0.01% 144
2025
Q4 		$2.97K Hold
1,046
– – ﹤0.01% 144
2025
Q3 		$2.77K Buy
+1,046
New +$8.55K ﹤0.01% 130
2025
Q1 		– Sell
-5,474
Closed -$508K – 112
2024
Q4 		$508K Buy
+5,474
New +$472K 0.22% 71

Other funds holding JBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return